0000000000147935

AUTHOR

Eleni A Georgakopoulou

showing 2 related works from this author

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03%

2020

Background Exfoliative and erosive cheilitis, may be a source of speech and chewing discomfort, but may also be an aesthetic issue for the patients affected. Such a clinical presentation may implicate a variety of inflammatory conditions, including atopic (eczematous) cheilitis. Topical and systemic agents, e.g. corticosteroids, have been used to treat inflammatory lip conditions. Topical tacrolimus has also been used in some inflammatory lip conditions. Material and Methods We performed a retrospective clinical analysis of atopic cheilitis patients. Results Between 2015 and 2020, we addressed 7 (seven) patients with atopic dermatitis affecting only lips and were diagnosed as atopic-eczemat…

osseodensificationprimary stabilitymedicine.medical_specialtyAdministration TopicalEsthetics DentalTacrolimuslow density boneAtopymedicineHumansGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesrfaOral Medicine and PathologyClinical pathologybusiness.industryResearchAtopic dermatitisTopical tacrolimusmedicine.diseaseDermatologyLipTacrolimusbody regionsstomatognathic diseasesTreatment OutcomeCheilitisOtorhinolaryngologyConcomitantSurgerybusinessImmunosuppressive AgentsMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Oral non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate

2015

Oral non-Hodgkin’s lymphomas (O-NHLs) are a rare group of diverse lymphoid tissue malignancies and represent less than 5% of the oral cavity malignancies and 2% of all extra-nodal NHLs. Oral-NHLs affect the Waldeyer’s-ring, the salivary glands, the bone of the jaws and the oral mucosa, their clinical appearance is very heterogeneous. Among the risk factors for NHLs are immunosuppression (primary or secondary), autoimmunity and inflammation. O-NHLs share the same risk factors. This case report describes a patient with O-NHL which was possibly linked to the combination of methotrexate and etanercept for the treatment of her rheumatoid arthritis. To our knowledge this is probably among the fir…

medicine.medical_specialtyCase ReportOdontologíaMalignancyEtanerceptimmune system diseaseshemic and lymphatic diseasesmedicineMedical historyOral mucosaGeneral DentistryOral Medicine and Pathologybusiness.industrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludNon-Hodgkin's lymphomaLymphomastomatognathic diseasesmedicine.anatomical_structureRheumatoid arthritisUNESCO::CIENCIAS MÉDICASImmunologyMethotrexatebusinessmedicine.drug
researchProduct